Search alternatives:
web decrease » _ decrease (Expand Search)
ms decrease » _ decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a web » _ web (Expand Search)
10 i » 1 i (Expand Search), 10 _ (Expand Search), 16 i (Expand Search)
web decrease » _ decrease (Expand Search)
ms decrease » _ decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a web » _ web (Expand Search)
10 i » 1 i (Expand Search), 10 _ (Expand Search), 16 i (Expand Search)
-
921
-
922
-
923
-
924
-
925
-
926
-
927
Morphology, nucleation, and isothermal crystallization kinetics of poly(butylene succinate) mixed with a polycarbonate/MWCNTs masterbatch
Published 2018“…The nanocomposites contained 0.5, 1.0, 2.0, and 4.0 wt% MWCNTs. Differential scanning calorimetry (DSC), small angle X-ray scattering (SAXS) and wide angle X-ray scattering (WAXS) results indicate that the blends are partially miscible, hence they form two phases (i.e., PC-rich and PBS-rich phases). …”
Get full text
Get full text
-
928
-
929
-
930
-
931
-
932
-
933
-
934
-
935
-
936
-
937
-
938
-
939
-
940
In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes)
Published 2023“…Patient cohorts with excessive polypharmacy (≥9 medications) had the highest probability of survival up to 1.6 years compared to those with lower medication thresholds (≤4); the mortality rate decreased by 18% for patients with excessive polypharmacy [HR=0.82, 95% CI: 0.71 – 0.94]). …”
Get full text
Get full text
Get full text